News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöeller-Kipper
Thursday, May 25, 2023Mainz Biomed NV NASDAQMYNZ Mainz Biomed or the Company a molecular genetics diagnostic company specializing in the early detection of cancer announced today initial results from its colorectal cancer CRC screening campaign through its BGM betrieblich...
Touchlight Completes Expansion, Creating One of the World’s Largest DNA Manufacturing Facilities in London, UK
Thursday, May 25, 2023Touchlight a company pioneering enzymatic DNA production a critical material in many new genetic medicine treatments has completed the redevelopment and expansion of its UK manufacturing facility housed in a repurposed Victorian waterworks on the ban...
Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder
Wednesday, May 24, 2023Camurus NASDAQ STO CAMX today announces that the US Food and Drug Administration FDA has approved Brixadi buprenorphine extended release injection for subcutaneous SC use a weekly and monthly medication for the treatment of moderate to severe opioid...
Societal CDMO Enters Agreement With Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor Modulator
Wednesday, May 24, 2023Societal CDMO Inc Societal CDMO Nasdaq SCTL a contract development and manufacturing organization CDMO dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development today announced that it h...
TraceLink and PharmaLink Partner to Simplify DSCSA Compliance for Pharmacies, Hospitals, and Healthcare Providers
Tuesday, May 23, 2023TraceLink Inc the leading digital network platform company enabling endtoend product orchestration by connecting more than healthcare and life sciences entities through its BN IntegrateOnce network announced a partnership with PharmaLink the nations...
Vesselon Discovery Protects and Expands Drug Franchises
Tuesday, May 23, 2023In a major development Vesselon has discovered how to protect a superior method of delivering drugs shown to be effective in more than independent preclinical and cliniciansponsored human trials Despite compelling evidence that the method improves t...
Haisate Pharmaceuticals announced that the US FDA approved its Phase III clinical trial of TC Ointment, the world's first new plant small molecule drug for the treatment of psoriasis vulgaris
Tuesday, May 23, 2023Hessate Pharmaceuticals announced today through its whollyowned research institution Guangzhou Psoriasis Research Institute PRIG that based on the completed Phase IIb of the new drug in the United States Clinical trial NCT the US Food and Drug Admini...
Lifecore Biomedical Enters into $150.0 Million in New Financing
Tuesday, May 23, 2023Lifecore Biomedical Inc Lifecore or the Company Nasdaq LFCR a fully integrated contract development and manufacturing organization CDMO today announced that it has entered into a broad set of agreements with its longterm customer Alcon SIXNYSE ALC wh...
HiST Pharma Announces U.S. FDA Approval to Start a Phase III Clinical Trial of TC Cream - the World's First Plant-Based "Small Molecule" Drug to Treat Psoriasis Vulgaris
Monday, May 22, 2023HiST Pharma through its wholly owned Psoriasis Research Institute of Guangzhou PRIG announces today that it has received approval from the US Food and Drug Administration FDA to develop its new investigational drug IND Include TC Cream for the treatm...
AlzeCure's Alzheimer project NeuroRestore ACD856 is also granted a European patent
Monday, May 22, 2023AlzeCure Pharma AB publ FN STO ALZCUR developing small molecule drug candidates for CNS diseases focusing on Alzheimers disease and pain announced today that the European Patent Office EPO has granted a patent covering the companys drug candidate ACD...
